The inflammation activation of tumor cells and cancer treatments can induce the tryptophan-degrading enzyme indoleamine 2,3-dioxygenase, which can convert tryptophan to kynurenine in the gastrointestinal tract and other tissues of the body [99]. Here, IDO2 is linked to neoplasm.